Oncoinvent ASA (CHIX:ONCINO) 3-Month Share Buyback Ratio: 0.00% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ONCINO Oncoinvent ASA CHIX:ONCINO
47 GF Score
Price kr1,039.91
GF Value kr2,473.94
! 5 Warning Signs
View Full Analysis

What is Oncoinvent ASA 3-Month Share Buyback Ratio?

Oncoinvent ASA CHIX:ONCINO 47 3-Month Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates CHIX:ONCINO with a GF Score™ of 47/100 and a GF Value™ of kr2,473.94. The stock has 5 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

CHIX:ONCINO
47GF Score
Oncoinvent ASA CHIX:ONCINO
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
Oncoinvent ASA (CHIX:ONCINO) has a 3-Month Share Buyback Ratio of 0.00 as of Jun. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Oncoinvent ASA and its competitors.
Is Oncoinvent ASA's 3-Month Share Buyback Ratio too high?
Oncoinvent ASA's current 3-Month Share Buyback Ratio is 0.00. Overall, Oncoinvent ASA has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Oncoinvent ASA's 3-Month Share Buyback Ratio compare to VRTX and REGN?
Oncoinvent ASA's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Biotechnology company?
A good 3-Month Share Buyback Ratio depends on the Biotechnology industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Oncoinvent ASA and its competitors. Oncoinvent ASA's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncoinvent ASA stock overvalued right now?
Oncoinvent ASA (CHIX:ONCINO) has a current 3-Month Share Buyback Ratio of 0.00. The stock's GF Value™ is kr2,473.94, compared to a current price of kr1,039.91 — trading 58% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. Oncoinvent ASA's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Oncoinvent ASA (CHIX:ONCINO), the current 3-Month Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncoinvent ASA (CHIX:ONCINO) Overvalued in 2026?

Based on GuruFocus' analysis, Oncoinvent ASA stock appears to be undervalued. The current stock price of kr1,039.91 is trading 58% below its estimated GF Value™ of kr2,473.94.

Key valuation signals for CHIX:ONCINO:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: kr2,473.94 vs. price of kr1,039.91 (58% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ONCINO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oncoinvent ASA Business Description

Address Gullhaugveien 7, Oslo, NOR, 0484
Oncoinvent ASA is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. Its key product candidate is Radspherin, a receptor-independent alpha radiation therapy that leverages the anatomy of the abdominal cavity to destroy residual micrometastases using a single, localized dose of alpha radiation. Radspherin is currently in clinical development in two indications: peritoneal metastasis from ovarian and colorectal cancer, but it is also relevant for treating peritoneal metastasis from other cancer types and potentially metastatic cancer in other body cavities. Geographically, the company operates in Norway.
47GF Score

Get the complete analysis for CHIX:ONCINO

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1,039.91
Price
kr2,473.94
GF Value